Evidence map›Paper›PMID 41089725›Full record

ArticleMaterials today. Bio2025

Dual-magnetically driven nanozymes for glioblastoma immunotherapy via magnetothermal and NIR-amplified ferroptosis and apoptosis.

Hui Liu, Xiaochuan Yang, Xianwen Liang, Ying Xia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Spatiotemporal cancer controlNanomedicine (London, England) · 2026
    Review
  3. Size-Dependent Immunomodulatory Effects of FeMolecules (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hui LiuDepartment of Interventional Radiology, Xiangya School of Medicine Affiliated Haikou Hospital, Central South University, Haikou City, Hainan, 570203, China.
Xiaochuan YangDepartment of Interventional Radiology, Xiangya School of Medicine Affiliated Haikou Hospital, Central South University, Haikou City, Hainan, 570203, China.
Xianwen LiangSchool of Food Science and Engineering, Hainan University, Haikou City, Hainan, 570203, China.
Ying XiaDepartment of Neurosurgery, Xiangya School of Medicine Affiliated Haikou Hospital, Central South University, Haikou City, Hainan, 570203, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hindrance posed by the blood-brain barrier (BBB) and the unique characteristics of the tumor microenvironment (TME) remain major challenges in glioblastoma (GBM) therapy. Here, we developed a dual-magnetically driven ultrasmall Mo

Indexed as

ApoptosisBlood-brain barrierDual-magnetically drivenFerroptosisImmunotherapyNanozyme

Identifiers

PMID41089725
PMCPMC12517174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.